Swiss health tech company Sophia Genetics lands $30 mln Series D
Sophia Genetics, a Swiss health tech company, has secured $30 million in Series D funding. Balderton Capital led the round with participation from 360º Capital Partners, Invoke Capital and Alychlo.
13 September 2017•1 min read
